challenges of dual-targeted car t-cell therapy
Published 2 years ago • 298 plays • Length 1:13Download video MP4
Download video MP3
Similar videos
-
1:52
opportunities and challenges for dual-targeting car-t therapy in all
-
3:03
using dual-targeting car-ts to overcome caf-induced car-t resistance in multiple myeloma
-
3:18
evaluating dual-targeting cd19/22 car-t cells in patients with r/r all
-
1:38
challenges of car-t therapy in the real-world setting
-
2:47
current challenges with car t-cell therapy
-
4:16
the challenges with car t-cell therapy for t-all and the progress made to overcome these challenges
-
0:46
challenges associated with the use of off-the-shelf car-t products in multiple myeloma
-
4:06
car-t therapy in all: exploring dual-targeting of cd19 & cd22 to overcome resistance
-
4:04
overcoming challenges in car t-cell therapy for multiple myeloma
-
6:22
current challenges faced with car t-cell therapies
-
1:51
regulatory and commercialization challenges with car t-cell therapy
-
3:02
the challenges of using car-t cell therapy to treat patients with cll
-
1:51
challenges with car t-cell therapy
-
1:44
challenges in developing car-t therapy for aml
-
1:19
challenges for access to car t-cell therapy
-
3:32
nursing & car t-cell therapy: challenges and roles
-
3:14
using machine learning to identify trajectories of hematotoxicity following car t-cell therapy
-
3:12
challenges in car t-cell therapy
-
3:29
challenges of car-t therapy in clinical practice: clinical trials vs real-world data